Aurobindo One Step Closer To Xolair Biosimilar Registration

Subsidiary CuraTeQ Completes Phase I Trial With Primary Endpoints Achieved

Competitors running on arrow racetrack
• Source: Shutterstock

More from Biosimilars

More from Products